(Q38092069)

28 August 2017

title

Why do we need drugs to treat the patient with obesity? (English)

1 reference

28 August 2017

0 references

1

George A Bray

1 reference

28 August 2017

language of work or name

1 reference

1 May 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

21

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

893-899

1 reference

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

28 August 2017

cites work

1 reference

Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008

21 January 2018

1 reference

Increased food energy supply is more than sufficient to explain the US epidemic of obesity.

21 January 2018

1 reference

Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity.

21 January 2018

1 reference

Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society

21 January 2018

1 reference

21 January 2018

1 reference

Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy

21 January 2018

1 reference

Medical Consequences of Obesity

21 January 2018

1 reference

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

21 January 2018

1 reference

Psychosocial origins of obesity stigma: toward changing a powerful and pervasive bias

21 January 2018

1 reference

Weight bias among health professionals specializing in obesity

21 January 2018

1 reference

Economic causes and consequences of obesity

21 January 2018

1 reference

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial

21 January 2018

1 reference

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

Lifestyle change and mobility in obese adults with type 2 diabetes

21 January 2018

1 reference

Obstructive sleep apnea among obese patients with type 2 diabetes

21 January 2018

1 reference

Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice

21 January 2018

1 reference

Effect of weight loss with lifestyle intervention on risk of diabetes

21 January 2018

1 reference

Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial

21 January 2018

1 reference

Changes in quality of life and body image after gastric bypass surgery

21 January 2018

1 reference

Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes

21 January 2018

1 reference

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

21 January 2018

1 reference

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

21 January 2018

1 reference

Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients

21 January 2018

1 reference

Four-year weight losses in the Look AHEAD study: factors associated with long-term success

21 January 2018

1 reference

Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial

21 January 2018

1 reference

Food and Drug Administration's Obesity Drug Guidance Document: a short history.

21 January 2018

1 reference

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

Evaluation of drugs for treating obesity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.20394

1 reference

28 August 2017

1 reference